CannaKids & SavingSophie.org
Tracy Ryan is the CEO and lead consultant for CannaKids, a California based cooperative with a focus on supplying medical cannabis oil to adults and children looking for holistic relief for serious health conditions, specializing in pediatric cancer.
Since her infant daughter’s brain tumor diagnosis in June of 2013, Tracy has dedicated a huge part of her life to educating herself on the medicinal powers of medical marijuana in treating her own daughter’s disease, as well as all other pediatric and adult cancers, epilepsy, autism and beyond. Tracy has worked on a global scale with families who are seeking education, and treatment options for their loved ones, and has guided many patients to unheard of success. CannaKids is now on a trajectory to be one of the world’s leaders for cannabinoid therapies based on scientific research and is in collaboration with some of the top researchers, doctors, and hospitals in the world.
With a true passion for clinical research, Tracy has successfully secured a relationship with the Technion Institute in Israel who are leading the way in cannabis research for cancer.
In addition to the research in Israel, CannaKids is in the planning phase with a major hospital in the Los Angeles area and is expected to start in-hospital clinical trials on pediatric patients next year.
Tracy is also the Vice Chair for the Women’s Grow LA Chapter, and as a
public speaker, can be found speaking at medical cannabis and pediatric
cancer events all over the world in her quest to educate the mass public on
the power of this incredible plant.
In addition, the Ryan family is the key focus of the Abby Epstein and Ricki Lake documentary, “Weed the People”, releasing next year. They have also been featured in many national and international news pieces including, NationalGeographic.com, Vice News, Entertainment Tonight, and many more.
As an educator, activist, and self-proclaimed “Momcologist”, it is Tracy’s
mission to uncover the mysteries behind this plant in hopes to formulate
disease specific cannabinoid formulations for patients of all ages.